VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
ALCAlcon Inc.
$64.68$31.5B
Research
OverviewAnalysis
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

ALC logoAlcon Inc.(ALC)Earnings, Financials & Key Ratios

ALC•NYSE
32.7× P/E·Price updated Jun 19, 2026
SectorHealthcareIndustryMedical InstrumentsSub-IndustryDental and vision care devices
AboutAlcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under the PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.Show more
  • Revenue$10.4B+4.9%
  • EBITDA$2.55B-3.4%
  • Net Income$980M-3.7%
  • EPS (Diluted)1.98-3.4%
  • Gross Margin55.24%-0.7%
  • EBITDA Margin24.53%-8.0%
  • Operating Margin13.08%-8.3%
  • Net Margin9.42%-8.3%
  • ROE4.5%-6.8%

ALC Key Insights

Alcon Inc. (ALC) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓FCF machine: 16.6% free cash flow margin
  • ✓High quality earnings: Operating CF exceeds net income
  • ✓Trading at only 1.5x book value

✗Weaknesses

  • ✗Weak 3Y average ROE of 4.7%
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when ALC posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

ALC Price & Volume

Alcon Inc. (ALC) stock price & volume — 10-year historical chart

Loading chart...

ALC Growth Metrics

Alcon Inc. (ALC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years4.78%
5 Years8.77%
3 Years6.06%
TTM6.61%

Profit CAGR

10 Years12.71%
5 Years-
3 Years43.02%
TTM-27.2%

EPS CAGR

10 Years12.5%
5 Years-
3 Years42.8%
TTM-26.67%

Return on Capital

10 Years1.48%
5 Years3.73%
3 Years4.6%
Last Year4.81%

ALC Recent Earnings

Alcon Inc. (ALC) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 8/12 qtrs (67%)●Beat Revenue 5/12 qtrs (42%)
Q2 2026Latest
May 5, 2026
Metric
Actual
Est
EPS
$0.85+6.3%
$0.80
Rev
$2.7B+0.4%
$2.6B
Q1 2026
Feb 24, 2026
Metric
Actual
Est
EPS
$0.78-1.3%
$0.79
Rev
$2.6B-1.9%
$2.7B
Q4 2025
Nov 11, 2025
Metric
Actual
Est
EPS
$0.79+2.6%
$0.77
Rev
$2.6B-3.6%
$2.7B
Q3 2025
Aug 19, 2025
Metric
Actual
Est
EPS
$0.76+7.0%
$0.71
Rev
$2.6B-2.1%
$2.7B
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 5, 2026
$0.85vs $0.80+6.3%
$2.7Bvs $2.6B+0.4%
Q1 2026Feb 24, 2026
$0.78vs $0.79-1.3%
$2.6Bvs $2.7B-1.9%
Q4 2025Nov 11, 2025
$0.79vs $0.77+2.6%
$2.6Bvs $2.7B-3.6%
Q3 2025Aug 19, 2025
$0.76vs $0.71+7.0%
$2.6Bvs $2.7B-2.1%
Based on last 12 quarters of dataView full earnings history →

ALC Peer Comparison

Alcon Inc. (ALC) competitors in Dental and vision care devices — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
BAX logoBAXBaxter International Inc.Direct Competitor10.27B19.89-11.375.72%-9.7%-16.5%1.64
HSIC logoHSICHenry Schein, Inc.Direct Competitor9.17B79.9224.444.03%3.02%8.24%0.77
HOLX logoHOLXHologic, Inc.Direct Competitor16.97B76.0130.531.74%13.18%11.01%0.52
IDXX logoIDXXIDEXX Laboratories, Inc.Direct Competitor44.64B562.0942.9710.42%24.63%70.87%0.67
EW logoEWEdwards Lifesciences CorporationDirect Competitor50.37B87.3647.7411.55%17.64%10.35%0.07
STE logoSTESTERIS plcDirect Competitor19.89B202.6125.558.73%13.18%11.04%0.27
JNJ logoJNJJohnson & JohnsonProduct Competitor550.4B228.3939.454.3%27.26%31.69%0.51
ABT logoABTAbbott LaboratoriesProduct Competitor153.68B88.3811.574.59%31.88%27.26%0.32

Compare ALC vs Peers

Alcon Inc. (ALC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs BAX

Most directly comparable listed peer for ALC.

Scale Benchmark

vs LLY

Larger-name benchmark to compare ALC against a more recognizable public peer.

Peer Set

Compare Top 5

vs BAX, HSIC, HOLX, IDXX

ALC Income Statement

Alcon Inc. (ALC) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
6.79B7.15B7.51B6.83B8.29B8.72B9.46B9.91B10.4B10.58B
Revenue Growth %
2.97%5.32%4.96%-8.99%21.34%5.14%8.47%4.82%4.94%6.61%
Cost of Goods Sold
3.59B3.96B3.85B3.89B3.64B3.97B4.21B4.4B4.66B4.77B
COGS % of Revenue
52.83%55.38%51.23%56.97%43.89%45.53%44.51%44.39%44.76%-
Gross Profit
3.2B▲ 0%
3.19B▼ 0.4%
3.66B▲ 14.7%
2.94B▼ 19.7%
4.65B▲ 58.2%
4.75B▲ 2.1%
5.25B▲ 10.5%
5.51B▲ 5.1%
5.75B▲ 4.2%
5.81B▲ 0%
Gross Margin %
47.17%44.62%48.77%43.03%56.11%54.47%55.49%55.62%55.24%54.95%
Gross Profit Growth %
2.99%-0.37%14.72%-19.72%58.23%2.06%10.51%5.05%4.23%-
Operating Expenses
3.28B3.44B3.85B3.42B4.07B4.08B4.21B4.1B4.38B4.51B
OpEx % of Revenue
48.31%48.09%51.27%50.08%49.11%46.76%44.51%41.36%42.16%-
Selling, General & Admin
2.6B2.8B2.85B2.69B3.08B3.07B3.21B3.25B3.45B3.48B
SG&A % of Revenue
38.22%39.16%37.92%39.43%37.1%35.2%33.94%32.79%33.16%-
Research & Development
584M587M656M673M842M702M859M876M990M1.01B
R&D % of Revenue
8.6%8.21%8.74%9.85%10.16%8.05%9.09%8.84%9.52%-
Other Operating Expenses
101M52M346M55M154M306M140M-27M-54M1000K
Operating Income
-77M▲ 0%
-248M▼ 222.1%
-187M▲ 24.6%
-482M▼ 157.8%
580M▲ 220.3%
672M▲ 15.9%
1.04B▲ 54.6%
1.41B▲ 36.0%
1.36B▼ 3.8%
1.3B▲ 0%
Operating Margin %
-1.13%-3.47%-2.49%-7.05%7%7.71%10.99%14.26%13.08%12.31%
Operating Income Growth %
-870%-222.08%24.6%-157.75%220.33%15.86%54.61%36%-3.75%-
EBITDA
1.24B1.38B1.28B1.24B1.8B1.83B2.26B2.64B2.55B2.17B
EBITDA Margin %
18.27%19.27%16.99%18.17%21.73%21.01%23.9%26.65%24.53%20.53%
EBITDA Growth %
-1.46%11.04%-7.45%-2.67%45.13%1.68%23.37%16.86%-3.41%2.98%
D&A (Non-Cash Add-back)
1.32B1.63B1.46B1.72B1.22B1.16B1.22B1.23B1.19B866.05M
EBIT
-101M-274M-206.28M-542.6M539.14M616.59M1.02B1.45B1.16B1.26B
Net Interest Income
-27M-21.84M-126.23M-125.3M-117.25M-121.87M-155M-104.73M-204M-221.99M
Interest Income
01.99M8.21M6.37M3.01M16.52M34M81.45M00
Interest Expense
27M23.83M134.44M131.67M120.26M138.4M189M186.18M0152.99M
Other Income/Expense
-50M-52M-145M-153M-162M-209M-207M-157M-200M-321.52M
Pretax Income
-127M▲ 0%
-300M▼ 136.2%
-332M▼ 10.7%
-635M▼ 91.3%
418M▲ 165.8%
463M▲ 10.8%
832M▲ 79.7%
1.26B▲ 51.0%
1.16B▼ 7.6%
981.34M▲ 0%
Pretax Margin %
-1.87%-4.19%-4.42%-9.29%5.04%5.31%8.8%12.67%11.15%9.27%
Income Tax
-383M-73M324M-104M42M128M-142M238M180M166.01M
Effective Tax Rate %
301.57%24.33%-97.59%16.38%10.05%27.65%-17.07%18.95%15.52%16.92%
Net Income
256M▲ 0%
-227M▼ 188.7%
-656M▼ 189.0%
-531M▲ 19.1%
376M▲ 170.8%
335M▼ 10.9%
974M▲ 190.7%
1.02B▲ 4.5%
980M▼ 3.7%
815.33M▲ 0%
Net Margin %
3.77%-3.17%-8.74%-7.77%4.54%3.84%10.3%10.27%9.42%7.71%
Net Income Growth %
250.59%-188.67%-188.99%19.05%170.81%-10.9%190.75%4.52%-3.73%-27.2%
Net Income (Continuing)
256M-227M-656M-531M376M335M974M1.02B980M815.33M
Discontinued Operations
0000000000
Minority Interest
000000001M1.01M
EPS (Diluted)
0.52▲ 0%
-0.46▼ 188.5%
-1.34▼ 191.3%
-1.09▲ 18.7%
0.76▲ 169.7%
0.68▼ 10.5%
1.96▲ 188.2%
2.05▲ 4.6%
1.98▼ 3.4%
1.66▲ 0%
EPS Growth %
248.57%-188.46%-191.3%18.66%169.72%-10.53%188.24%4.59%-3.41%-26.67%
EPS (Basic)
0.52-0.46-1.34-1.090.770.681.982.061.99-
Diluted Shares Outstanding
488.7M488.7M488.2M489M493.4M494.4M496.5M497.5M496.2M490.2M
Basic Shares Outstanding
488.7M488.7M488.2M489M490M491.4M493M494.4M494.95M487.2M
Dividend Payout Ratio
----14.39%30.83%11.91%12.77%16.94%-

ALC Balance Sheet

Alcon Inc. (ALC) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
3.29B3.4B4.24B4.99B5.39B5.19B5.65B6.31B6.45B6.66B
Cash & Short-Term Investments
172M258M855M1.57B1.58B980M1.1B1.83B1.61B1.67B
Cash Only
172M227M822M1.56B1.57B980M1.09B1.68B1.53B1.59B
Short-Term Investments
031M33M12M3M07M154M80M81.44M
Accounts Receivable
1.52B1.41B1.51B1.47B1.59B1.99B1.89B2.08B1.94B2.02B
Days Sales Outstanding
81.5871.7473.5178.4270.1383.2872.8176.6868.1568.25
Inventory
1.3B1.44B1.5B1.64B1.9B2.11B2.32B2.27B2.39B2.45B
Days Inventory Outstanding
132.55132.69142.83154.14190.47193.95201.41188.18187.44185.04
Other Current Assets
237M249M275M213M224M8M226M12M509M515.8M
Total Non-Current Assets
24.1B23.66B23.42B22.61B22.61B24.02B23.97B24.04B25.11B25.14B
Property, Plant & Equipment
2.56B2.88B3.44B3.78B4.08B4.42B4.72B4.84B5.22B5.25B
Fixed Asset Turnover
2.65x2.48x2.18x1.81x2.03x1.97x2.00x2.05x1.99x2.05x
Goodwill
8.89B8.9B8.9B8.9B8.9B8.97B8.93B8.95B9.26B9.31B
Intangible Assets
11.54B10.68B10.23B9.1B8.77B9.69B9.06B8.59B9.01B8.93B
Long-Term Investments
51M86M59M40M52M108M319M751M768M3.07B
Other Non-Current Assets
528M450M433M389M399M422M496M495M855M378.05M
Total Assets
27.39B▲ 0%
27.06B▼ 1.2%
27.66B▲ 2.2%
27.6B▼ 0.2%
28B▲ 1.4%
29.21B▲ 4.3%
29.61B▲ 1.4%
30.35B▲ 2.5%
31.55B▲ 4.0%
31.79B▲ 0%
Asset Turnover
0.25x0.26x0.27x0.25x0.30x0.30x0.32x0.33x0.33x0.34x
Asset Growth %
-1.27%-1.19%2.19%-0.2%1.45%4.32%1.39%2.48%3.98%15.84%
Total Current Liabilities
1.78B1.89B2.3B2.26B2.47B2.74B2.4B2.28B3.05B3.02B
Accounts Payable
672M663M833M876M903M861M811M773M926M924.01M
Days Payables Outstanding
68.3661.0979.0582.1390.5779.1870.3564.1472.5969.66
Short-Term Debt
65M47M261M169M107M97M48M101M575M660.58M
Deferred Revenue (Current)
138M94M97M110M108M89M77.97M72.84M00
Other Current Liabilities
417M490M559M532M586M907M627.03M539.16M1.47B1.23B
Current Ratio
1.85x1.80x1.84x2.21x2.18x1.90x2.35x2.77x2.12x2.20x
Quick Ratio
1.12x1.03x1.19x1.48x1.41x1.13x1.39x1.77x1.33x1.39x
Cash Conversion Cycle
145.77143.34137.28150.42170.03198.05203.87200.72183183.63
Total Non-Current Liabilities
2.58B2.53B6.05B6.52B6.27B6.75B6.59B6.52B6.47B6.52B
Long-Term Debt
01.83B3.22B3.95B3.97B4.54B4.68B4.54B4.16B4.18B
Capital Lease Obligations
84M89M280M315M339M359M335M429M429M1.75B
Deferred Tax Liabilities
1.64B1.53B1.39B1.2B1.03B1.06B797M724M02.72B
Other Non-Current Liabilities
857M-918M1.17B1.06B940M786M752M739M1.88B938.08M
Total Liabilities
4.36B4.42B8.35B8.78B8.74B9.53B8.99B8.79B9.52B9.54B
Total Debt
149M136M3.8B4.5B4.48B5.07B5.13B5.14B5.25B5.29B
Net Debt
-23M-91M2.98B2.94B2.9B4.09B4.04B3.45B3.72B3.7B
Debt / Equity
0.01x0.01x0.20x0.24x0.23x0.26x0.25x0.24x0.24x0.24x
Debt / EBITDA
0.12x0.10x2.98x3.62x2.49x2.77x2.27x1.94x2.06x2.44x
Net Debt / EBITDA
-0.02x-0.07x2.34x2.37x1.61x2.23x1.79x1.31x1.46x1.71x
Interest Coverage
-3.74x-11.50x-1.53x-4.12x4.48x4.46x5.40x7.78x-8.23x
Total Equity
23.03B▲ 0%
22.64B▼ 1.7%
19.3B▼ 14.7%
18.82B▼ 2.5%
19.26B▲ 2.3%
19.68B▲ 2.2%
20.62B▲ 4.8%
21.55B▲ 4.5%
22.04B▲ 2.2%
22.25B▲ 0%
Equity Growth %
0.07%-1.69%-14.74%-2.49%2.31%2.19%4.81%4.5%2.24%12.14%
Book Value per Share
47.1246.3239.5438.4939.0339.8041.5443.3244.4145.40
Total Shareholders' Equity
23.03B22.64B19.3B18.82B19.26B19.68B20.62B21.55B22.03B22.25B
Common Stock
022.64B20M20M20M20M20M20M20M20.11M
Retained Earnings
22.94B22.65B-547M0000000
Treasury Stock
0000000000
Accumulated OCI
87M-11M19.28B18.8B19.24B19.66B20.6B21.53B22.01B22.23B
Minority Interest
000000001M1.01M

ALC Cash Flow Statement

Alcon Inc. (ALC) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
1.22B1.14B920M823M1.34B1.22B1.39B2.08B2.27B2.27B
Operating CF Margin %
17.93%15.94%12.25%12.04%16.22%13.96%14.68%20.96%21.83%-
Operating CF Growth %
-2.17%-6.4%-19.3%-10.54%63.43%-9.52%14.05%49.64%9.34%40.58%
Net Income
256M-227M-656M-531M376M335M974M1.02B980M815.33M
Depreciation & Amortization
1.3B1.62B1.43B1.62B1.22B1.12B1.22B1.23B1.19B1.02B
Stock-Based Compensation
71M93M83M105M138M140M144M150M0-80M
Deferred Taxes
-383M-73M324M-104M42M128M-142M238M00
Other Non-Cash Items
53M-355M-208M-225M-116M13M-377.78M-368M400M770.94M
Working Capital Changes
-84M80M-48M-45M-314M-522M-431.22M-189M-300M-253.79M
Change in Receivables
-54M53M-115M43M-198M-164M-117.41M-55M05.78M
Change in Inventory
-87M-150M-108M-159M-326M-217M-289.26M-47M0-2.4M
Change in Payables
044M84M-21M60M-48M-54.44M-15M03.93M
Cash from Investing
-679M-1B-1.01B-572M-1.2B-1.86B-1.09B-1.17B-1.34B-971.35M
Capital Expenditures
-496M-712M-676M-567M-1.18B-745M-660M-473M-543M-639.38M
CapEx % of Revenue
7.3%9.95%9%8.3%14.23%8.55%6.98%4.77%5.22%6.04%
Acquisitions
-70M-239M-283M6.37M480M-666M-10M-220M-692M-114.96M
Investments
----------
Other Investing
1M0-1M-82M-480M-485M-177.3M-205M-109M-181.69M
Cash from Financing
-539M-78M659M466M-123M-8M-211M-322M-1.12B-1.13B
Debt Issued (Net)
-112.11M-5.96M3.36B536M-63M208M-7M-137M-96M-50.68M
Equity Issued (Net)
000-16M-22M-50M-49M0-723M-758.01M
Dividends Paid
0000-54.11M-103.28M-116M-130M-166M-160.65M
Share Repurchases
000-16M-22M-50M-49M0-723M-758.01M
Other Financing
-426.89M-72.04M-2.7B-54M16.11M-62.72M-39M-55M-134M-156.4M
Net Change in Cash
10M▲ 0%
55M▲ 450.0%
595M▲ 981.8%
735M▲ 23.5%
18M▼ 97.6%
-595M▼ 3405.6%
114M▲ 119.2%
582M▲ 410.5%
-149M▼ 125.6%
169.4M▲ 0%
Free Cash Flow
722M▲ 0%
428M▼ 40.7%
244M▼ 43.0%
256M▲ 4.9%
165M▼ 35.5%
472M▲ 186.1%
537M▲ 13.8%
1.41B▲ 162.0%
1.73B▲ 22.8%
1.7B▲ 0%
FCF Margin %
10.63%5.98%3.25%3.75%1.99%5.41%5.68%14.2%16.61%16.11%
FCF Growth %
-2.3%-40.72%-42.99%4.92%-35.55%186.06%13.77%162.01%22.81%5.57%
FCF per Share
1.480.880.500.520.330.951.082.833.483.48
FCF Conversion (FCF/Net Income)
4.76x-5.02x-1.40x-1.55x3.58x3.63x1.43x2.04x2.32x2.09x
Interest Paid
00000000063M
Taxes Paid
0000000000

ALC Key Ratios

Alcon Inc. (ALC) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
1.11%-0.99%-3.13%-2.79%1.97%1.72%4.83%4.83%4.5%3.69%
Return on Invested Capital (ROIC)
-0.25%-0.82%-0.63%-1.64%1.98%2.19%3.22%4.27%4.02%3.78%
Gross Margin
47.17%44.62%48.77%43.03%56.11%54.47%55.49%55.62%55.24%54.95%
Net Margin
3.77%-3.17%-8.74%-7.77%4.54%3.84%10.3%10.27%9.42%7.71%
Debt / Equity
0.01x0.01x0.20x0.24x0.23x0.26x0.25x0.24x0.24x0.24x
Interest Coverage
-3.74x-11.50x-1.53x-4.12x4.48x4.46x5.40x7.78x-8.23x
FCF Conversion
4.76x-5.02x-1.40x-1.55x3.58x3.63x1.43x2.04x2.32x2.09x
Revenue Growth
2.97%5.32%4.96%-8.99%21.34%5.14%8.47%4.82%4.94%6.61%
Related:ALC Dividend History·ALC Revenue History·ALC Price History·ALC P/E History·ALC Financial Ratios·ALC Institutional Holders

ALC Frequently Asked Questions

Alcon Inc. (ALC) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Alcon Inc. (ALC) reported $10.58B in revenue for fiscal year 2025. This represents a 62% increase from $6.52B in 2015.

Alcon Inc. (ALC) grew revenue by 4.9% over the past year. Growth has been modest.

Yes, Alcon Inc. (ALC) is profitable, generating $815.3M in net income for fiscal year 2025 (9.4% net margin).

Dividend & Returns

Yes, Alcon Inc. (ALC) pays a dividend with a yield of 0.52%. This makes it attractive for income-focused investors.

Alcon Inc. (ALC) has a return on equity (ROE) of 4.5%. This is below average, suggesting room for improvement.

Alcon Inc. (ALC) generated $1.70B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in ALC back in 2015?

Total return calculator · dividends reinvested · 11+ years of data

See returns →

How much would $100/month in ALC be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →